why choose us

First received: May 08, 2023

Clinical Trial: Isatuximab in Lung Transplant Recipients

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Antibody-mediated Rejection

Study Type: INTERVENTIONAL


Official Title: A Pilot Study of Isatuximab in Addition to Standard Therapy for Desensitization or Antibody-mediated Rejection in Lung Transplant Recipients

Brief Summary: The purpose of this study is to determine the safety and feasibility of adding isatuximab to standard of care therapies in patients who will receive a lung transplant, but have significant antibodies against the donor (desensitization), or patients who have previously received a lung transplant and develop antibodies against the donor (antibody-mediated rejection, AMR).The study will compare the impact of isatuximab on the recurrence of antibodies after they have been removed from the blood by a process known as…

Read more